Terms: = Lymphoma AND TCL1A, P56279, 8115, ENSG00000100721, TCL1
149 results:
1. Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations.
Shumilov E; Mazzeo P; Ghandili S; Künstner A; Weidemann S; Banz Y; Ströbel P; Pollak M; Kolloch L; Beltraminelli H; Kerkhoff A; Mikesch JH; Schliemann C; Haase D; Wulf G; Legros M; Lenz G; Feldmeyer L; Pabst T; Witte H; Gebauer N; Bacher U
Ann Hematol; 2024 May; 103(5):1587-1599. PubMed ID: 38194088
[TBL] [Abstract] [Full Text] [Related]
2. A Multiplex Biomarker Assay Improves the Prediction of Survival in Epithelial Ovarian Cancer.
Dobilas A; Åkesson A; Leandersson P; Borgfeldt C
Cancer Genomics Proteomics; 2023; 20(3):273-280. PubMed ID: 37093685
[TBL] [Abstract] [Full Text] [Related]
3. Isoform-specific knockdown of long and intermediate prolactin receptors interferes with evolution of B-cell neoplasms.
Taghi Khani A; Kumar A; Sanchez Ortiz A; Radecki KC; Aramburo S; Lee SJ; Hu Z; Damirchi B; Lorenson MY; Wu X; Gu Z; Stohl W; Sanz I; Meffre E; Müschen M; Forman SJ; Koff JL; Walker AM; Swaminathan S
Commun Biol; 2023 Mar; 6(1):295. PubMed ID: 36941341
[TBL] [Abstract] [Full Text] [Related]
4. From the archives of MD Anderson Cancer Center: Aleukemic T-prolymphocytic leukemia, a rare presentation and review of the literature.
Nahmod KA; Thakral B; Aakash FNU; Iyer SP; Medeiros LJ; Quesada AE
Ann Diagn Pathol; 2023 Feb; 62():152077. PubMed ID: 36549077
[TBL] [Abstract] [Full Text] [Related]
5. Macrophage- and BCR-derived but not TLR-derived signals support the growth of CLL and Richter syndrome murine models in vivo.
Martines C; Chakraborty S; Vujovikj M; Gobessi S; Vaisitti T; Deaglio S; Laurenti L; Dimovski AJ; Efremov DG
Blood; 2022 Dec; 140(22):2335-2347. PubMed ID: 36084319
[TBL] [Abstract] [Full Text] [Related]
6. AID overexpression leads to aggressive murine CLL and nonimmunoglobulin mutations that mirror human neoplasms.
Morande PE; Yan XJ; Sepulveda J; Seija N; Marquez ME; Sotelo N; Abreu C; Crispo M; Fernández-Graña G; Rego N; Bois T; Methot SP; Palacios F; Remedi V; Rai KR; Buschiazzo A; Di Noia JM; Navarrete MA; Chiorazzi N; Oppezzo P
Blood; 2021 Jul; 138(3):246-258. PubMed ID: 34292322
[TBL] [Abstract] [Full Text] [Related]
7. Novel Therapeutic Approaches in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Era of Targeted Therapy.
Wilson NR; Konopleva M; Khoury JD; Pemmaraju N
Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):734-740. PubMed ID: 34226167
[TBL] [Abstract] [Full Text] [Related]
8. tcl1a, B Cell Regulation and Tolerance in Renal Transplantation.
Brinas F; Danger R; Brouard S
Cells; 2021 Jun; 10(6):. PubMed ID: 34206047
[TBL] [Abstract] [Full Text] [Related]
9. AKT: a key to RT?
Brown JR
Blood; 2021 Feb; 137(5):582-584. PubMed ID: 33538799
[TBL] [Abstract] [Full Text] [Related]
10. EOMES and IL-10 regulate antitumor activity of T regulatory type 1 CD4
Roessner PM; Llaó Cid L; Lupar E; Roider T; Bordas M; Schifflers C; Arseni L; Gaupel AC; Kilpert F; Krötschel M; Arnold SJ; Sellner L; Colomer D; Stilgenbauer S; Dietrich S; Lichter P; Izcue A; Seiffert M
Leukemia; 2021 Aug; 35(8):2311-2324. PubMed ID: 33526861
[TBL] [Abstract] [Full Text] [Related]
11. Current understandings on T-cell prolymphocytic leukemia and its association with tcl1 proto-oncogene.
Sun S; Fang W
Biomed Pharmacother; 2020 Jun; 126():110107. PubMed ID: 32247279
[TBL] [Abstract] [Full Text] [Related]
12. tcl1 as a hub protein associated with the PI3K/AKT signaling pathway in diffuse large B-cell lymphoma based on proteomics methods.
Gao HX; Li SJ; Niu J; Ma ZP; Nuerlan A; Xue J; Wang MB; Cui WL; Abulajiang G; Sang W; Zhang W; Li XX
Pathol Res Pract; 2020 Feb; 216(2):152799. PubMed ID: 31932115
[TBL] [Abstract] [Full Text] [Related]
13. The tcl1 function revisited focusing on metabolic requirements of stemness.
Fiorenza MT; Rava A
Cell Cycle; 2019 Nov; 18(22):3055-3063. PubMed ID: 31564197
[TBL] [Abstract] [Full Text] [Related]
14. CD8
Llaó Cid L; Hanna BS; Iskar M; Roessner PM; Öztürk S; Lichter P; Zapatka M; Seiffert M
Leuk Lymphoma; 2020 Feb; 61(2):351-356. PubMed ID: 31519123
[TBL] [Abstract] [Full Text] [Related]
15. SLAMF6 as a Regulator of Exhausted CD8
Yigit B; Wang N; Ten Hacken E; Chen SS; Bhan AK; Suarez-Fueyo A; Katsuyama E; Tsokos GC; Chiorazzi N; Wu CJ; Burger JA; Herzog RW; Engel P; Terhorst C
Cancer Immunol Res; 2019 Sep; 7(9):1485-1496. PubMed ID: 31315913
[TBL] [Abstract] [Full Text] [Related]
16. Eμ-tcl1xMyc: A Novel Mouse Model for Concurrent CLL and B-Cell lymphoma.
Lucas F; Rogers KA; Harrington BK; Pan A; Yu L; Breitbach J; Bundschuh R; Goettl VM; Hing ZA; Kanga P; Mantel R; Sampath D; Smith LL; Wasmuth R; White DK; Yan P; Byrd JC; Lapalombella R; Woyach JA
Clin Cancer Res; 2019 Oct; 25(20):6260-6273. PubMed ID: 31296529
[TBL] [Abstract] [Full Text] [Related]
17. Comparative transcriptome analysis of peripheral blood mononuclear cells in renal transplant recipients in everolimus- and tacrolimus-based immunosuppressive therapy.
Granata S; Santoro G; Signorini L; Malerba G; Patuzzo C; Gambaro G; Stallone G; Zaza G
Eur J Pharmacol; 2019 Sep; 859():172494. PubMed ID: 31238062
[TBL] [Abstract] [Full Text] [Related]
18. Loss of NFAT2 expression results in the acceleration of clonal evolution in chronic lymphocytic leukemia.
Müller DJ; Wirths S; Fuchs AR; Märklin M; Heitmann JS; Sturm M; Haap M; Kirschniak A; Sasaki Y; Kanz L; Kopp HG; Müller MR
J Leukoc Biol; 2019 Mar; 105(3):531-538. PubMed ID: 30556925
[TBL] [Abstract] [Full Text] [Related]
19. Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia.
McMaster ML; Berndt SI; Zhang J; Slager SL; Li SA; Vajdic CM; Smedby KE; Yan H; Birmann BM; Brown EE; Smith A; Kleinstern G; Fansler MM; Mayr C; Zhu B; Chung CC; Park JH; Burdette L; Hicks BD; Hutchinson A; Teras LR; Adami HO; Bracci PM; McKay J; Monnereau A; Link BK; Vermeulen RCH; Ansell SM; Maria A; Diver WR; Melbye M; Ojesina AI; Kraft P; Boffetta P; Clavel J; Giovannucci E; Besson CM; Canzian F; Travis RC; Vineis P; Weiderpass E; Montalvan R; Wang Z; Yeager M; Becker N; Benavente Y; Brennan P; Foretova L; Maynadie M; Nieters A; de Sanjose S; Staines A; Conde L; Riby J; Glimelius B; Hjalgrim H; Pradhan N; Feldman AL; Novak AJ; Lawrence C; Bassig BA; Lan Q; Zheng T; North KE; Tinker LF; Cozen W; Severson RK; Hofmann JN; Zhang Y; Jackson RD; Morton LM; Purdue MP; Chatterjee N; Offit K; Cerhan JR; Chanock SJ; Rothman N; Vijai J; Goldin LR; Skibola CF; Caporaso NE
Nat Commun; 2018 Oct; 9(1):4182. PubMed ID: 30305637
[TBL] [Abstract] [Full Text] [Related]
20. Splicing modulation sensitizes chronic lymphocytic leukemia cells to venetoclax by remodeling mitochondrial apoptotic dependencies.
Ten Hacken E; Valentin R; Regis FFD; Sun J; Yin S; Werner L; Deng J; Gruber M; Wong J; Zheng M; Gill AL; Seiler M; Smith P; Thomas M; Buonamici S; Ghia EM; Kim E; Rassenti LZ; Burger JA; Kipps TJ; Meyerson ML; Bachireddy P; Wang L; Reed R; Neuberg D; Carrasco RD; Brooks AN; Letai A; Davids MS; Wu CJ
JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282833
[TBL] [Abstract] [Full Text] [Related]
[Next]
